Overview

A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients

Status:
Terminated
Trial end date:
2016-04-08
Target enrollment:
Participant gender:
Summary
This study is to evaluate efficacy and safety of tacrolimus with steroid by observing remission rate at 24 weeks in lupus nephritis patients who are non-responders to steroid monotherapy.
Phase:
Phase 4
Details
Lead Sponsor:
Astellas Pharma Korea, Inc.
Treatments:
Tacrolimus